Aránega A - Search Results

1

Reverse transcriptase-polymerase chain reaction detection of circulating tumor cells in patients with melanoma: correlation with clinical stage, tumor thickness and histological type.

Carrillo E, Prados J, Melguizo C, Marchal JA, Vélez C, Serrano S, Boulaiz H, Mérida JA, Aránega A. Carrillo E, et al. Among authors: aranega a. Pathol Int. 2002 Apr;52(4):294-9. doi: 10.1046/j.1440-1827.2002.01344.x. Pathol Int. 2002. PMID: 12031085

2

Prognostic value of RT-PCR tyrosinase detection in peripheral blood of melanoma patients.

Carrillo E, Prados J, Marchal JA, Boulaiz H, Martínez A, Rodríguez-Serrano F, Caba O, Serrano S, Aránega A. Carrillo E, et al. Among authors: aranega a. Dis Markers. 2006;22(3):175-81. doi: 10.1155/2006/462065. Dis Markers. 2006. PMID: 16788251 Free PMC article.

3

Optimization of the tyrosinase mRNA probe to detect circulating melanocytes with reverse transcription and polymerase chain reaction.

Carrillo E, Marchal JA, Prados J, Melguizo C, Vélez C, Arena N, Alvarez L, Serrano S, Aránega A. Carrillo E, et al. Among authors: aranega a. Cell Mol Biol (Noisy-le-grand). 1998 Dec;44(8):1247-52. Cell Mol Biol (Noisy-le-grand). 1998. PMID: 9874512

4

Transfection of MS-36 melanoma cells with gef gene inhibits proliferation and induces modulation of the cell cycle.

Boulaiz H, Prados J, Marchal JA, García AM, Alvarez L, Melguizo C, Carrillo E, Ramos JL, Aránega A. Boulaiz H, et al. Among authors: aranega a. Cancer Sci. 2003 Jun;94(6):564-8. doi: 10.1111/j.1349-7006.2003.tb01483.x. Cancer Sci. 2003. PMID: 12824883 Free PMC article.

5

Ultrastructural and molecular analyzes of insulin-producing cells induced from human hepatoma cells.

Perán M, Sánchez-Ferrero A, Tosh D, Marchal JA, Lopez E, Alvarez P, Boulaiz H, Rodríguez-Serrano F, Aranega A. Perán M, et al. Among authors: aranega a. Cytotherapy. 2011 Feb;13(2):193-200. doi: 10.3109/14653249.2010.501791. Epub 2010 Jul 22. Cytotherapy. 2011. PMID: 20662611

6

Creatine kinase isoenzymes as markers of differentiation in rhabdomyosarcoma cells in culture.

Fernández JE, Prados J, Melguizo C, Rodríguez F, Alvarez L, Aránega A. Fernández JE, et al. Among authors: aranega a. Pathol Res Pract. 1994 Dec;190(12):1169-73. doi: 10.1016/S0344-0338(11)80443-7. Pathol Res Pract. 1994. PMID: 7792206

7

Differentiation of a human rhabdomyosarcoma cell line after antineoplastic drug treatment.

Melguizo C, Prados J, Aneiros J, Fernandez JE, Velez C, Aranega A. Melguizo C, et al. Among authors: aranega a. J Pathol. 1995 Jan;175(1):23-9. doi: 10.1002/path.1711750105. J Pathol. 1995. PMID: 7891223

8

Low concentrations of actinomycin D potentially cause therapeutic differentiation in human rhabdomyosarcoma cell line RD.

Melguizo C, Prados J, Marchal JA, Aránega AE, Alvarez L, Aránega A. Melguizo C, et al. Among authors: aranega a, aranega ae. Pathol Res Pract. 1996 Feb;192(2):188-94. doi: 10.1016/S0344-0338(96)80219-6. Pathol Res Pract. 1996. PMID: 8692721

9

Inverse expression of mdr 1 and c-myc genes in a rhabdomyosarcoma cell line resistant to actinomycin d.

Prados J, Melguizo C, Fernández A, Aránega AE, Alvarez L, Aránega A. Prados J, et al. Among authors: aranega a, aranega ae. J Pathol. 1996 Sep;180(1):85-9. doi: 10.1002/(SICI)1096-9896(199609)180:1<85::AID-PATH626>3.0.CO;2-7. J Pathol. 1996. PMID: 8943821

10

Therapeutic differentiation in a human rhabdomyosarcoma cell line selected for resistance to actinomycin D.

Prados J, Melguizo C, Marchal JA, Vélez C, Alvarez L, Aránega A. Prados J, et al. Among authors: aranega a. Int J Cancer. 1998 Jan 30;75(3):379-83. doi: 10.1002/(sici)1097-0215(19980130)75:3<379::aid-ijc9>3.0.co;2-#. Int J Cancer. 1998. PMID: 9455797

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

232 results

Search Page

Filters